137 related articles for article (PubMed ID: 9083624)
1. Construction of artificial methemoglobin reduction systems in Hb vesicles.
Takeoka S; Ohgushi T; Sakai H; Kose T; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1997; 25(1-2):31-41. PubMed ID: 9083624
[TBL] [Abstract][Full Text] [Related]
2. Methemoglobin formation in hemoglobin vesicles and reduction by encapsulated thiols.
Takeoka S; Sakai H; Kose T; Mano Y; Seino Y; Nishide H; Tsuchida E
Bioconjug Chem; 1997; 8(4):539-44. PubMed ID: 9258453
[TBL] [Abstract][Full Text] [Related]
3. Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin.
Faivre B; Menu P; Labrude P; Grandgeorge M; Vigneron C
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):551-8. PubMed ID: 7527721
[TBL] [Abstract][Full Text] [Related]
4. Potential electron mediators to extract electron energies of RBC glycolysis for prolonged in vivo functional lifetime of hemoglobin vesicles.
Kettisen K; Bülow L; Sakai H
Bioconjug Chem; 2015 Apr; 26(4):746-54. PubMed ID: 25734688
[TBL] [Abstract][Full Text] [Related]
5. Effects of the pH-controlled hemoglobin vesicles by CO2 gas.
Park S; Kose T; Hamasaki M; Takeoka S; Nishide H; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):497-506. PubMed ID: 9844716
[TBL] [Abstract][Full Text] [Related]
6. Red blood cells donate electrons to methylene blue mediated chemical reduction of methemoglobin compartmentalized in liposomes in blood.
Sakai H; Li B; Lim WL; Iga Y
Bioconjug Chem; 2014 Jul; 25(7):1301-10. PubMed ID: 24877769
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin vesicles containing methemoglobin and L-tyrosine to suppress methemoglobin formation in vitro and in vivo.
Atoji T; Aihara M; Sakai H; Tsuchida E; Takeoka S
Bioconjug Chem; 2006; 17(5):1241-5. PubMed ID: 16984134
[TBL] [Abstract][Full Text] [Related]
8. Prolonged oxygen-carrying ability of hemoglobin vesicles by coencapsulation of catalase in vivo.
Teramura Y; Kanazawa H; Sakai H; Takeoka S; Tsuchida E
Bioconjug Chem; 2003; 14(6):1171-6. PubMed ID: 14624631
[TBL] [Abstract][Full Text] [Related]
9. Reduction of methemoglobin via electron transfer from photoreduced flavin: restoration of O2-binding of concentrated hemoglobin solution coencapsulated in phospholipid vesicles.
Sakai H; Masada Y; Onuma H; Takeoka S; Tsuchida E
Bioconjug Chem; 2004; 15(5):1037-45. PubMed ID: 15366957
[TBL] [Abstract][Full Text] [Related]
10. Intravascular reduction of methemoglobin in plasma of the rat in vivo.
den Boer PJ; Bleeker WK; Rigter G; Agterberg J; Stekkinger P; Kannegieter LM; de Nijs IM; Bakker JC
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):647-50. PubMed ID: 1391489
[TBL] [Abstract][Full Text] [Related]
11. The reduction of methemoglobin in Neo Red Cell.
Ohki N; Kimura T; Ogata Y
Artif Cells Blood Substit Immobil Biotechnol; 1998 Nov; 26(5-6):477-85. PubMed ID: 9844714
[TBL] [Abstract][Full Text] [Related]
12. Prolonged functional life span of artificial red cells in blood circulation by repeated methylene blue injections.
Sakai H; Leong C
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3123-3128. PubMed ID: 31352837
[TBL] [Abstract][Full Text] [Related]
13. Hidden Antioxidative Functions of Reduced Nicotinamide Adenine Dinucleotide Coexisting with Hemoglobin.
Yamada M; Sakai H
ACS Chem Biol; 2017 Jul; 12(7):1820-1829. PubMed ID: 28485916
[TBL] [Abstract][Full Text] [Related]
14. The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs.
Wicks D; Wong LT; Sandhu R; Stewart RK; Biro GP
Artif Cells Blood Substit Immobil Biotechnol; 2003 Feb; 31(1):1-17. PubMed ID: 12602813
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of electron mediators for the reduction of methemoglobin encapsulated in liposomes using electron energies produced by red blood cell glycolysis.
Ghirmai S; Bülow L; Sakai H
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1364-1372. PubMed ID: 29103319
[TBL] [Abstract][Full Text] [Related]
16. Reduction and suppression of methemoglobin loaded in the polymeric nanoparticles intended for blood substitutes.
Zhang X; Liu C; Yuan Y; Shan X; Sheng Y; Xu F
J Biomed Mater Res B Appl Biomater; 2008 Nov; 87(2):354-63. PubMed ID: 18464252
[TBL] [Abstract][Full Text] [Related]
17. Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro.
Quebec EA; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):693-705. PubMed ID: 8556142
[TBL] [Abstract][Full Text] [Related]
18. Scalable manufacturing platform for the production of methemoglobin as a non-oxygen carrying control material in studies of cell-free hemoglobin solutions.
Gu X; Hickey R; Rath A; Palmer AF
PLoS One; 2022; 17(2):e0263782. PubMed ID: 35171971
[TBL] [Abstract][Full Text] [Related]
19. Methemoglobin reductase activity in intact fish red blood cells.
Jensen FB; Nielsen K
Comp Biochem Physiol A Mol Integr Physiol; 2018 Feb; 216():14-19. PubMed ID: 29133139
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of electron transfer to coordinated dioxygen of oxyhemoglobins to yield peroxide and methemoglobin. Protein control of electron donation by aquopentacyanoferrate(II).
Kawanishi S; Caughey WS
J Biol Chem; 1985 Apr; 260(8):4622-31. PubMed ID: 3988729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
